The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases
CONCLUSIONS: Across the reviewed disease areas, behavioral interventions and pharmacotherapies are shown to be critical components of clinical practice. Over the last 20 years, novel pharmaceutical innovations have been incorporated into clinical practice guideline recommendations; however, with varying speeds of adoption. Given the increasing pace of pharmacologic innovation, timely updates of clinical practice guidelines are critical to evolving the standard of care and practicing evidence-based medicine.PMID:38505696 | PMC:PMC10950408 | DOI:10.1155/2024/5877687
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Meaghan Roach Natalie Land Jennifer Hernandez Reina Rau Jacquelyn W Chou Stacey S Hickson Danielle F Rollmann J Ross Maclean Source Type: research
More News: Alzheimer's | Cancer | Cancer & Oncology | Cardiology | Chronic Obstructive Pulmonary | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Disease | Lung Cancer | Non-Small Cell Lung Cancer | Study